Clinical Trial Update: Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating psilocybin plus multidisciplinary palliative care in demoralized cancer survivors with chronic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Solid Tumor

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Emory University | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 1 | Status: COMPLETED